⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RNAC News
Cartesian Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
RNAC
Form 8-K
sec.gov
RNAC
Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
RNAC
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
RNAC
Cartesian Therapeutics Announces New Employment Inducement Grants
globenewswire.com
RNAC
Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook
globenewswire.com
RNAC
Cartesian Therapeutics Announces New Employment Inducement Grants
globenewswire.com
RNAC
Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors
globenewswire.com
RNAC
Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis
globenewswire.com
RNAC
Cartesian Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
RNAC